Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from British American Tobacco ( (GB:BATS) ).
British American Tobacco announced a £1.3 billion share buy-back and reaffirmed its guidance for 2026, expecting a 2% growth in revenue and adjusted profit for FY25. The company is experiencing strong momentum in the U.S. market, driven by its combustibles and Velo Plus products, and is seeing improvements in its Vuse vapour products due to increased enforcement against illicit products. The company is focused on accelerating growth in its New Category segment, with Velo showing strong performance globally. Despite challenges in certain regions, BAT remains confident in its mid-term growth targets and is committed to reducing leverage and delivering shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4733.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
Spark’s Take on GB:BATS Stock
According to Spark, TipRanks’ AI Analyst, GB:BATS is a Outperform.
British American Tobacco’s overall score is driven by strong technical indicators and positive corporate events, including share buybacks and executive share acquisitions. While financial performance shows robust cash flow, concerns about earnings volatility and a high P/E ratio slightly temper the outlook. The company’s strategic initiatives in innovation and digital transformation are promising, but challenges in specific markets require attention.
To see Spark’s full report on GB:BATS stock, click here.
More about British American Tobacco
British American Tobacco is a leading company in the tobacco industry, primarily offering products such as cigarettes and new category products like vaping and modern oral products. The company focuses on expanding its market presence in the U.S. and other key regions, while also investing in new categories to drive future growth.
Average Trading Volume: 4,891,096
Technical Sentiment Signal: Buy
Current Market Cap: £93.12B
See more insights into BATS stock on TipRanks’ Stock Analysis page.